BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7904721)

  • 1. Granulocyte-macrophage colony-stimulating factor and tumor necrosis factor alpha in patients with human immunodeficiency virus (HIV) type 1 infection.
    Hober D; Ajana F; Petit MC; Sartiaux C; Boniface M; Caillaux M; Mouton Y; Wattre P; Maniez-Montreuil M
    Microbiol Immunol; 1993; 37(10):785-92. PubMed ID: 7904721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GM-CSF production by CD4+ T-lymphocytes is selectively impaired during the course of HIV-1 infection. A possible indication of a preferential lesion of a specific subset of peripheral blood CD4+ T-lymphocytes.
    Re MC; Zauli G; Furlini G; Giovannini M; Ranieri S; Ramazzotti E; Vignoli M; La Placa M
    Microbiologica; 1992 Jul; 15(3):265-70. PubMed ID: 1354325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro response of T cells from aplastic anemia patients to antilymphocyte globulin and phytohemagglutinin: colony-stimulating activity and lymphokine production.
    Tong J; Bacigalupo A; Piaggio G; Figari O; Sogno G; Marmont A
    Exp Hematol; 1991 Jun; 19(5):312-6. PubMed ID: 1902792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dendritic cells generated in the presence of granulocyte-macrophage colony-stimulating factor and IFN-alpha are potent inducers of HIV-specific CD8 T cells.
    Carbonneil C; Aouba A; Burgard M; Cardinaud S; Rouzioux C; Langlade-Demoyen P; Weiss L
    AIDS; 2003 Aug; 17(12):1731-40. PubMed ID: 12891059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Granulocyte-macrophage colony-stimulating factor induces modest increases in plasma human immunodeficiency virus (HIV) type 1 RNA levels and CD4+ lymphocyte counts in patients with uncontrolled HIV infection.
    Jacobson JM; Lederman MM; Spritzler J; Valdez H; Tebas P; Skowron G; Wang R; Jackson JB; Fox L; Landay A; Gilbert MJ; O'Neil D; Bancroft L; Al-Harthi L; Jacobson MA; Merigan TC; Glesby MJ;
    J Infect Dis; 2003 Dec; 188(12):1804-14. PubMed ID: 14673758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor (G-CSF) induces the production of cytokines in vivo.
    Xu S; Höglund M; Hâkansson L; Venge P
    Br J Haematol; 2000 Mar; 108(4):848-53. PubMed ID: 10792294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1-infected peripheral blood mononuclear cells enhance neutrophil survival and HLA-DR expression via increased production of GM-CSF: implications for HIV-1 infection.
    Fu J; Sha BE; Thomas LL
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):16-25. PubMed ID: 20975570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of human immunodeficiency virus and colony-stimulating factors on the production of interleukin 6 and tumor necrosis factor alpha by monocyte/macrophages.
    Foli A; Saville MW; May LT; Webb DS; Yarchoan R
    AIDS Res Hum Retroviruses; 1997 Jul; 13(10):829-39. PubMed ID: 9197377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlates with the number of circulating CFU-gm in HIV-1 seropositive subjects.
    Bagnara GP; Zauli G; Re MC; Furlini G; Giovannini M; Ranieri S; Brizzi MF; La Placa M
    Int J Cell Cloning; 1991 May; 9(3):239-50. PubMed ID: 1676406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydrocortisone inhibits granulocyte-macrophage colony-stimulating factor production from normal human peripheral blood mononuclear cells and CD3+ T cells.
    Chikkappa G; Lansing LS; Chu RC; Pasquale D
    Exp Hematol; 1998 Dec; 26(13):1240-6. PubMed ID: 9845380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The plasma levels and diagnostic utility of granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage - colony stimulating factor (GM-CSF) in patients with I and II stage of breast cancer].
    Ławicki S; Czygier M; Wojtukiewicz M; Szmitkowski M
    Przegl Lek; 2009; 66(7):365-9. PubMed ID: 20043577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of granulocyte-macrophage colony stimulating factor and interleukin-1 production from human peripheral blood mononuclear cells as measured by specific radioimmunoassays.
    Katzen NA; Segal GM; Vannier E; Nerad JL; Klempner MS; Dinarello CA
    Eur Cytokine Netw; 1992; 3(4):365-72. PubMed ID: 1421010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Release of granulocyte-macrophage colony-stimulating factor by alveolar macrophages in the lung of HIV-1-infected patients. A mechanism accounting for macrophage and neutrophil accumulation.
    Agostini C; Trentin L; Zambello R; Bulian P; Caenazzo C; Cipriani A; Cadrobbi P; Garbisa S; Semenzato G
    J Immunol; 1992 Nov; 149(10):3379-85. PubMed ID: 1431112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin and granulocyte-macrophage colony-stimulating factor (GM-CSF) levels in sera of patients with HIV infection.
    Reddy MM; Grieco MH
    Int J STD AIDS; 1991; 2(2):128-32. PubMed ID: 2043705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration.
    Erger RA; Casale TB
    Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased granulocyte-macrophage colony-stimulating factor production by human neonatal blood mononuclear cells and T cells.
    English BK; Hammond WP; Lewis DB; Brown CB; Wilson CB
    Pediatr Res; 1992 Mar; 31(3):211-6. PubMed ID: 1373232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of TNFalpha and IL-6 by activated whole blood from HIV-1 infected patients detected by a one-stage procedure: relationship with the phenotype of HIV-1 isolates.
    Benyoucef S; Hober D; Shen L; Ajana F; De Groote D; Bocket-Mouton L; Gérard Y; Lion G; Vilain V; Wattré P
    Microbiol Immunol; 1997; 41(12):939-46. PubMed ID: 9492179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase III study of granulocyte-macrophage colony-stimulating factor in advanced HIV disease: effect on infections, CD4 cell counts and HIV suppression. Leukine/HIV Study Group.
    Angel JB; High K; Rhame F; Brand D; Whitmore JB; Agosti JM; Gilbert MJ; Deresinski S
    AIDS; 2000 Mar; 14(4):387-95. PubMed ID: 10770541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
    Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
    Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.